thrombocytosis

1. However, in primary thrombocytosis, especially if there are other risk factors for thrombosis.
   然而，原发性血小板增多症，尤其是有血栓风险时，需要接受治疗。
2. Correlation between thrombocytosis and clinicopathologic factors in esophageal carcinoma
   血小板计数增高与食管癌临床病理因素的相关性分析
3. Effects of Sodium Ozagrel in Primary Thrombocytosis Combined with Thrombosis
   奥扎格雷钠干预治疗原发性血小板增多症合并血栓形成的研究
4. Correlation between thrombocytosis and prognosis in patients with osteosarcoma
   骨肉瘤患者高血小板血症与预后的相关性分析
5. Clinical studies on relation between ovarian malignant tumor and thrombocytosis
   卵巢恶性肿瘤与血小板增多关系的临床研究
6. Poor prognosis associated with thrombocytosis and cyclooxygenase-2 ( COX-2) expression in aged patients with gastric carcinoma
   血小板增多、环氧化酶2在老年胃癌中表达及预后
7. The clinical appearance, laboratory examination and treatment in 19 cases of primary thrombocytosis are reported in this paper.
   本文报告了19例原发性血小板增多症的临床表现、实验室检查及治疗。
8. Clinic diagnostic value of thrombocytosis in patients with lung cancer
   血小板升高对肺癌的临床诊断价值
9. The expression of VEGF and thrombocytosis were related to the tumour size, depth, lymph node metastasis, vessel invasion and TNM stage ( P < 0.01), The prognosis of patients with thrombocytosis and expression of VEGF was poor.
   血小板增多、VEGF表达与肿瘤大小、浸润深度、淋巴结转移、TNM分期、血管癌栓密切相关（P<0.01），血小板增多、VEGF阳性表达与胃癌预后呈负相关。
10. This paper presents the clinical application of venin in coronary heart disease, cerebral vascular disease, cor pulmonale dermatosis, diabetes mellitus, primary thrombocytosis, peripheral vascular disease, nephrotic syndrome etc.
    介绍了蝮蛇毒在冠心病、脑血管疾病、肺心病、皮肤病、糖尿病、原发性血小板增多症、周围血管疾病、肾病综合征等疾病中的临床应用。
11. Conclusions There was a close relationship between platelets and lung cancer, thrombocytosis may be used as a prognostic reference indication in patients with lung cancer, so anti-platelet treatment is prerequisite to the patients with lung cancer in multidisciplinary synthetic therapy.
    结论血小板与肺癌的发生、发展和转移有关，血小板增多可作为一个预后判断因素，抗血小板治疗是肺癌综合治疗所必须的。
12. PV was characterized by erythrocytosis, but in most cases, there were erythrocytosis, guanulocytosis and thrombocytosis in bone marrow.
    尽管临床上PV以红细胞增多为主，但骨髓分析显示此病有红系、粒系、巨核细胞系三系增生。
13. Splenectomy often relieve the symptoms of patients with mechanical pressure, but splenectomy related mortality is high, can accelerate liver and extreme thrombocytosis.
    脾切除常可减轻患者的机械压迫症状，但脾切除的相关死亡率高，可加速肝大和极度的血小板增多。
14. Clinical manifestations of CML include splenomegaly, extreme elevation of peripheral white blood cells, increasing of immature granulocyte macrophage, alkali, eosinophilia, anemia and thrombocytosis.
    临床表现为脾脏肿大、外周血白细胞极度升高并出现幼稚粒细胞，嗜碱、嗜酸粒细胞增多，常有贫血、血小板增多。
15. Coronary artery damage risk factors include age, thrombocytosis, application of IVIG time.
    冠状动脉损害高危因素包括年龄、血小板升高、应用丙种球蛋白时间等。

noun

1. increase in the number of platelets in the blood which tends to cause clots to form